✉news WorldUS Politics first seen 3 d ago, last 3 d ago, peak #36
Novel heart drugs in focus at ESC Congress 2026
Original: Novel agents and familiar cardiovascular treatments revisited: inside ESC Congress 2026
The European Society of Cardiology's 2026 Congress is putting both new cardiovascular agents and established treatments back under the spotlight. Coverage highlights how novel therapies are being weighed against familiar, well-proven cardiovascular drugs, with clinicians and researchers debating what the latest trial data mean for everyday patient care and future treatment guidelines.
Why now: Cardiology specialists are following the congress for new trial results and updated guidance on cardiovascular treatment.
European Society of CardiologyESC Congress 2026
Evidence
- Novel agents and familiar cardiovascular treatments revisited: inside ESC Congress 2026 · Hospital Pharmacy Europe
API: https://socialmediatrends-api.osmike.com/v1/trends/3129158